The rest of your medication list belongs in the incretin conversation

An incretin discussion often begins with one new medicine. The clinical assessment needs a wider view: what you already take, why you take it and what has changed. A current medication list helps the prescriber consider the proposed treatment within that existing plan.

FDA recommends recording prescription and nonprescription medicines, vitamins and supplements. The point is not to decide for yourself which combination is acceptable. It is to give qualified professionals enough accurate information to assess it and explain any changes.

Build from the containers and current instructions

Use actual labels and the instructions you have received rather than memory alone. Include the product names and the details the clinician requests about dose and timing. Mark anything you no longer use so an outdated entry does not appear active.

If a label and a later instruction differ, preserve both and ask the responsible professional to reconcile them. Do not choose the version that seems more familiar. A medication list should expose uncertainty so it can be resolved, rather than quietly turn uncertainty into a confident but incorrect entry.

Include the professionals behind the prescriptions

Different clinicians may be treating different conditions. Record who prescribed each medicine and the pharmacy that dispenses it. Ask the new prescriber how relevant changes will be communicated to the existing team and which records are needed.

A telehealth platform may not automatically receive another practice's notes. Send information through the designated secure channel and confirm it arrived. Our drug-information guide helps distinguish a general educational source from the instructions for your own prescription.

Ask what the new plan changes

NIDDK advises discussing health conditions and other medicines when considering weight-management treatment. If the clinician recommends changing an existing prescription, ask which professional will direct that change and how follow-up will be arranged. Avoid combining partial instructions from two offices into a plan neither has reviewed.

Also ask what to do if another professional proposes a new medicine later. Keeping the record current is a continuing task, not just an enrollment requirement. A brief update can matter when a pharmacist or clinician assesses a new concern.

Keep one accessible version

Choose a format you can bring to appointments and update reliably. A paper list can be useful; a digital list can be useful. Neither format helps if it contains old information or is unavailable when needed. Let a trusted caregiver know where to find it if that fits your circumstances.

Bring the list into the follow-up conversation and any new provider assessment. This practical record connects the biological explanation of a medicine with the person and care system in which it will actually be used.